$OTLC·4

MATEON THERAPEUTICS INC · Jan 13, 5:02 PM ET

MATEON THERAPEUTICS INC 4

4 · MATEON THERAPEUTICS INC · Filed Jan 13, 2017

Insider Transaction Report

Form 4
Period: 2017-01-12
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2017-01-12$0.38/sh+550,000$206,250550,000 total
    Exercise: $0.38Exp: 2027-01-12Common Stock (550,000 underlying)
Footnotes (2)
  • [F1]Dr. Schwieterman was awarded options to purchase Mateon Therapeutics, Inc. common stock, $0.01 par value per share, pursuant to the Mateon Therapeutics, Inc. 2017 Equity Incentive Plan in connection with his service as President and Chief Executive Officer.
  • [F2]The Options will vest in forty-eight equal monthly installments beginning one month after the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION